Skip to main content

Make a Gift

This activity is approved for a total of 22 possible AMA PRA Category 1 Credits™.

Please see the course schedule for details on lectures that are approved for ABA MOCA 2.0® Type 2 Patient Safety* and Type 4 Quality Improvement** credits.

*This activity contributes to the patient safety CME requirement for the CME component of the American Board of Anesthesiology’s (ABA) redesigned Maintenance of Certification in AnesthesiologyTM (MOCA®) program, known as MOCA 2.0®. Please consult the ABA website, www.theABA.org, for a list of all MOCA 2.0 requirements.

*This activity contributes to the Quality Improvement component of the American Board of Anesthesiology’s (ABA) redesigned Maintenance of Certification in AnesthesiologyTM (MOCA®) program, known as MOCA 2.0®. Please consult the ABA website, www.theABA.org, for a list of all MOCA 2.0 Quality Improvement requirements and their associated point values.

When will I receive my CME credit?
You will receive documentation within 2 weeks of completing the course. CRNA’s will receive a digital certificate they will need to submit to the ANAA to secure credit. Physicians will receive a link from the UNC School of Medicine CME office with a transcript of your credits. Physicians please note: These credits will already have been reported to the ABA and will be visible on your account.

 

Accreditation Statement
The School of Medicine of the University of North Carolina at Chapel Hill is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Credit Statement
The School of Medicine of the University of North Carolina at Chapel Hill designates this live activity for a maximum of 22 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Disclosure statement
This activity has been planned and implemented under the sole supervision of the Course Director, Robert Isaak, MD, and the co-Course Director, Jacob Acton, MD, in association with the UNC Office of Continuing Professional Development (CPD). The course director and CPD staff have no relevant financial relationships with ineligible companies as defined by the ACCME.

Dr. Stuart Grant receives research support from SPR Therapeutics Inc.

None of the other presenters have relevant financial relationships with ineligible companies as defined by the ACCME.